HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by McCrone, P. Search for Related Content PubMed Articles by McCrone, P.

Health economic measures in schizophrenia research

Department of Health Service and Population Research, King's College London, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK. Email: p.mccrone{at}iop.kcl.ac.uk

Declaration of interest P.M. has received speaker fees from Eli Lilly and Janssen-Cilag.

Background It is essential in economic evaluations of schizophrenia interventions that all relevant costs are identified and measured appropriately. Also of importance is the way in which cost data are combined with information on outcomes.

Aims To examine the use of health economics in evaluations of interventions for schizophrenia.

Methods A review of the key methods used to estimate costs and to link costs and outcomes was conducted.

Results Costs fall on a number of different agencies and can be shortterm or long term. Cost-effectiveness analysis and cost–utility analysis are the most appropriate methods for combing cost and outcome data.

Conclusions Schizophrenia poses a number of challenges for economic evaluation.

This article has been cited by other articles:

				T. Burns Evolution of outcome measures in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s1 - s6. [Abstract] [Full Text] [PDF]